U.S. Customs and Border Protection (CBP) officers at Washington Dulles International Airport seized ecstasy and gamma-butyrolactone (GBL) in three separate international air cargo shipments on August 30.
Officers detected anomalies with each shipment and CBP narcotics detector dog Ginna alerted to the ecstasy parcel.
In one parcel, officers discovered nearly 50 grams of 3,4-Methylenedioxymethamphetamine (MDMA), commonly known as ecstasy, destined to an address in Greenville County, S.C.
Officers then discovered 317 grams of GBL in a parcel destined to Middlesex County, Mass., and another 317 grams of GBL destined to an address in Madison County, Ala.
GBL is a DEA Schedule 1 controlled substance in the United States, meaning that it has a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision.
According to the DEA, GBL is a chemical analogue of the schedule I controlled substance gamma-hydroxybutyric acid (GHB). GBL is an odorless, colorless, central nervous system depressant that has addictive properties and potentially severe health consequences. It is sold legally as an industrial solvent. Sexual predators have used GBL as precursor chemical in a date-rape drug, and others abuse GBL as a bodybuilding supplement.
These seizures are the second for CBP officers at Dulles airport in as many weeks. On August 22, officers seized five shipments that collectively contained 60 grams of ecstasy and 970 grams of GBL.